TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 141 filers reported holding TG THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $253,000 | -12.8% | 6,525 | +8.3% | 0.06% | -18.3% |
| Q1 2021 | $290,000 | -10.2% | 6,025 | -2.9% | 0.07% | -16.5% |
| Q4 2020 | $323,000 | +86.7% | 6,205 | -64.6% | 0.08% | +30.8% |
| Q1 2020 | $173,000 | -18.0% | 17,550 | -7.5% | 0.06% | -12.2% |
| Q4 2019 | $211,000 | +88.4% | 18,975 | -4.8% | 0.07% | +105.6% |
| Q3 2019 | $112,000 | -36.4% | 19,940 | -1.7% | 0.04% | -35.7% |
| Q2 2019 | $176,000 | +31.3% | 20,290 | +21.9% | 0.06% | +47.4% |
| Q1 2019 | $134,000 | +94.2% | 16,640 | -1.5% | 0.04% | +46.2% |
| Q4 2018 | $69,000 | -65.8% | 16,890 | -53.1% | 0.03% | -62.3% |
| Q3 2018 | $202,000 | -57.8% | 35,990 | -1.2% | 0.07% | -62.7% |
| Q2 2018 | $479,000 | -1.4% | 36,440 | +6.5% | 0.18% | -3.6% |
| Q1 2018 | $486,000 | – | 34,225 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 2,813,779 | $33,568,000 | 3.32% |
| Opaleye Management Inc. | 300,000 | $3,579,000 | 1.50% |
| BRIDGER MANAGEMENT, LLC | 3,068,315 | $36,605,000 | 1.21% |
| SECTORAL ASSET MANAGEMENT INC | 1,521,667 | $18,153,000 | 0.77% |
| STONERIDGE INVESTMENT PARTNERS LLC | 332,576 | $3,968,000 | 0.53% |
| Eventide Asset Management | 537,600 | $6,414,000 | 0.32% |
| Baker Brothers Advisors | 2,003,991 | $23,908,000 | 0.20% |
| Quantitative Systematic Strategies LLC | 25,270 | $302,000 | 0.08% |
| Candriam S.C.A. | 236,200 | $2,818,000 | 0.08% |
| COLUMBUS CIRCLE INVESTORS | 705,389 | $8,415,000 | 0.07% |